117347-38-3Relevant academic research and scientific papers
SUBSTITUTED PIPERAZINES AS CB1 ANTAGONISTS
-
Page/Page column 123, (2009/03/07)
Compounds of Formula (I): or pharmaceutically acceptable salts, solvates, or esters thereof, are useful in treating diseases or conditions mediated by CB1 receptors, such as metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, addiction (e.g., smoking cessation), gastrointestinal disorders, and cardiovascular conditions.
